دورية أكاديمية

Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

التفاصيل البيبلوغرافية
العنوان: Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
المؤلفون: Arrieta, Víctor A.Aff1, Aff2, Chen, Andrew X., Kane, J. Robert, Kang, Seong Jae, Kassab, Cynthia, Dmello, Crismita, Zhao, JunfeiAff3, Aff5, Burdett, Kirsten B., Upadhyayula, Pavan S., Lee-Chang, Catalina, Shilati, Joseph, Jaishankar, Dinesh, Chen, Li, Gould, Andrew, Zhang, Daniel, Yuan, Jinzhou, Zhao, Wenting, Ling, Xiaoyang, Burks, Jared K., Laffleur, Brice, Amidei, Christina, Bruce, Jeffrey N., Lukas, Rimas V., Yamaguchi, Jonathan T., Cieremans, David, Rothschild, Gerson, Basu, Uttiya, McCord, Matthew, Brat, Daniel J., Zhang, Hui, Cooper, Lee A. D., Zhang, Bin, Sims, Peter, Cloughesy, Tim F., Prins, Robert, Canoll, Peter, Stupp, RogerAff1, Aff11, Aff18, Heimberger, Amy B., Horbinski, CraigAff1, Aff14, Iwamoto, Fabio M.Aff12, IDs43018022003438_cor40, Rabadan, RaulAff3, Aff5, IDs43018022003438_cor41, Sonabend, Adam M.Aff1, IDs43018022003438_cor42
المصدر: Nature Cancer. 3(3):373-373
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:26621347
DOI:10.1038/s43018-022-00343-8